PABPN1: molecular function and muscle disease
Open Access
- 18 April 2013
- journal article
- review article
- Published by Wiley in The FEBS Journal
- Vol. 280 (17), 4230-4250
- https://doi.org/10.1111/febs.12294
Abstract
The polyadenosine RNA binding protein polyadenylate‐binding nuclear protein 1 (PABPN1) plays key roles in post‐transcriptional processing of RNA. Although PABPN1 is ubiquitously expressed and presumably contributes to control of gene expression in all tissues, mutation of the PABPN1 gene causes the disease oculopharyngeal muscular dystrophy (OPMD), in which a limited set of skeletal muscles are affected. A major goal in the field of OPMD research is to understand why mutation of a ubiquitously expressed gene leads to a muscle‐specific disease. PABPN1 plays a well‐documented role in controlling the poly(A) tail length of RNA transcripts but new functions are emerging through studies that exploit a variety of unbiased screens as well as model organisms. This review addresses (a) the molecular function of PABPN1 incorporating recent findings that reveal novel cellular functions for PABPN1 and (b) the approaches that are being used to understand the molecular defects that stem from expression of mutant PABPN1. The long‐term goal in this field of research is to understand the key molecular functions of PABPN1 in muscle as well as the mechanisms that underlie the pathological consequences of mutant PABPN1. Armed with this information, researchers can seek to develop therapeutic approaches to enhance the quality of life for patients afflicted with OPMD.Keywords
This publication has 118 references indexed in Scilit:
- The Poly(A)-Binding Protein Nuclear 1 Suppresses Alternative Cleavage and Polyadenylation SitesCell, 2012
- Alternative Polyadenylation Mediates MicroRNA Regulation of Muscle Stem Cell FunctionCell Stem Cell, 2012
- Progressive myopathy in an inducible mouse model of oculopharyngeal muscular dystrophyNeurobiology of Disease, 2012
- Modeling Oculopharyngeal Muscular Dystrophy in Myotube Cultures Reveals Reduced Accumulation of Soluble Mutant PABPN1 ProteinThe American Journal of Pathology, 2011
- A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNACell, 2011
- Mechanisms and Consequences of Alternative PolyadenylationMolecular Cell, 2011
- Antiprion drugs 6‐aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophyEMBO Molecular Medicine, 2011
- Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR MiceCell, 2010
- Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer CellsCell, 2009
- Protein factors in pre-mRNA 3′-end processingCellular and Molecular Life Sciences, 2007